ABC Heart Fail Cardiomyop 2022; 2(4): 420-421
How to Anticoagulate Patients with Heart Failure and Cancer?
Marcos José Pereira Renni
, Tatiana Abelin Saldanha Marinho
Patients with cancer have a high risk of deep vein thrombosis and pulmonary embolism, as well as a risk of developing atrial fibrillation (AF) secondary to antineoplastic treatment. These events have a poor prognosis and depend on factors related to the tumor and the ongoing therapy. They are usually elevated during the first 6 months of treatment.
[…]
How to Anticoagulate Patients with Heart Failure and Cancer?
Keywords: Anticoagulation; Cancer; Heart Failure
245
